Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

328 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study).
Kinoshita T, Shinoda M, Nishizaki Y, Shiraki K, Hirai Y, Kichikawa Y, Tsushima K, Shinkai M, Komura N, Yoshida K, Kido Y, Kakeya H, Uemura N, Kadota J. Kinoshita T, et al. Among authors: shinkai m. BMC Med. 2022 Sep 27;20(1):342. doi: 10.1186/s12916-022-02518-7. BMC Med. 2022. PMID: 36163020 Free PMC article. Clinical Trial.
Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study).
Kinoshita T, Shinoda M, Nishizaki Y, Shiraki K, Hirai Y, Kichikawa Y, Tsushima K, Shinkai M, Komura N, Yoshida K, Kido Y, Kakeya H, Uemura N, Kadota J. Kinoshita T, et al. Among authors: shinkai m. BMC Med. 2022 Dec 8;20(1):478. doi: 10.1186/s12916-022-02695-5. BMC Med. 2022. PMID: 36482439 Free PMC article. No abstract available.
Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults.
Sonoyama T, Iwata S, Shinkai M, Iwata-Yoshikawa N, Shiwa-Sudo N, Hemmi T, Ainai A, Nagata N, Matsunaga N, Tada Y, Homma T, Omoto S, Yokokawa Shibata R, Igarashi K, Suzuki T, Hasegawa H, Ariyasu M. Sonoyama T, et al. Among authors: shinkai m. Vaccine. 2023 Mar 10;41(11):1834-1847. doi: 10.1016/j.vaccine.2022.12.025. Epub 2022 Dec 16. Vaccine. 2023. PMID: 36572603 Free PMC article. Clinical Trial.
A case of reinfection with a different variant of SARS-CoV-2: case report.
Shimada N, Shinoda M, Takei H, Yoshida Y, Nishimura M, Kousaka M, Morikawa M, Sato T, Matsuse H, Shinkai M. Shimada N, et al. Among authors: shinkai m. Egypt J Intern Med. 2023;35(1):13. doi: 10.1186/s43162-023-00194-4. Epub 2023 Feb 8. Egypt J Intern Med. 2023. PMID: 36785595 Free PMC article.
High Fever, Wide Distribution of Viral Pneumonia, and Pleural Effusion are More Critical Findings at the First Visit in Predicting the Prognosis of COVID-19: A Single Center, retrospective, Propensity Score-Matched Case-Control Study.
Shinoda M, Ota S, Yoshida Y, Hirouchi T, Shinada K, Sato T, Morikawa M, Ishii N, Shinkai M. Shinoda M, et al. Among authors: shinkai m. Int J Gen Med. 2023 Jun 8;16:2337-2348. doi: 10.2147/IJGM.S408907. eCollection 2023. Int J Gen Med. 2023. PMID: 37313043 Free PMC article.
Surveillance of seasonal influenza viruses during the COVID-19 pandemic in Tokyo, Japan, 2018-2023, a single-center study.
Takahashi H, Nagamatsu H, Yamada Y, Toba N, Toyama-Kousaka M, Ota S, Morikawa M, Shinoda M, Takano S, Fukasawa S, Park K, Yano T, Mineshita M, Shinkai M. Takahashi H, et al. Among authors: shinkai m. Influenza Other Respir Viruses. 2024 Jan 5;18(1):e13248. doi: 10.1111/irv.13248. eCollection 2024 Jan. Influenza Other Respir Viruses. 2024. PMID: 38188373 Free PMC article.
Effectiveness and duration of additional immune defense provided by SARS-CoV-2 infection before and after receiving the mRNA COVID-19 vaccine BNT162b2.
Shimada N, Sugawa S, Murakami S, Shinoda M, Ota S, Morikawa M, Takei H, Serizawa Y, Takahashi H, Toyama-Kousaka M, Matsuse H, Shinkai M. Shimada N, et al. Among authors: shinkai m. Vaccine X. 2024 Jun 26;19:100518. doi: 10.1016/j.jvacx.2024.100518. eCollection 2024 Aug. Vaccine X. 2024. PMID: 39040888 Free PMC article.
328 results